Obesity remains one of the most commercially important areas in clinical development, but it is also one of the easiest places to misread recruitment performance.
Strong demand can make enrollment look easier than it really is. In practice, the challenge is not simply generating interest.
It is identifying the right patients early, educating them clearly, and moving them forward without adding avoidable burden to sites.
That distinction matters because obesity is not one uniform recruitment market. Broad studies may generate fast response, high screener volume, and strong patient intent.
But sponsor teams should not mistake top-of-funnel activity for downstream readiness.
What is an MFT?
A Market Feasibility Test (MFT) is a short, time-limited pre-campaign exercise used to assess whether the right patients can be reached, engaged, and qualified before a full recruitment program begins.
In recent obesity feasibility work completed by Antidote powered by 83bar, one obesity audience generated strong early response:
But a separate obesity feasibility test focused on a GLP-1 switch-study audience told a more operationally important story:
Engagement remained strong, but final qualification dropped sharply in the more protocol-specific audience.
And that’s the real signal for sponsor-side teams.
Reach is possible. Intent is possible.
But more selective obesity studies need more than demand generation alone.
When eligibility depends on medication history, stable dosing, prior weight-loss response, or other narrow criteria, recruitment efficiency depends on earlier filtering and better patient education.
This is where many obesity programs lose efficiency. If qualification happens too late, sites absorb the friction. Coordinators spend time reviewing patients who were never a true fit. Teams generate activity, but not enough site-ready progression.
The more useful question is no longer, “Can we find obesity patients?”
It’s, “Can we identify the right obesity patients early enough to protect site capacity, reduce preventable screening waste, and improve progression into enrollment?”
That is why a stronger recruitment model does more than drive traffic.
The obesity MFT materials point to that same conclusion, explicitly recommending an end-to-end model, including clinical contact center support, to further qualify and educate candidates before handoff.
In a crowded obesity market, volume alone is not a strategy.
Smarter qualification is.